Article
HCV NS3 quasispecies in liver and plasma and dynamics of telaprevir-resistant variants in breakthrough patients assessed by UDPS: A case study.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Nov 2015
Bartolini Barbara, Selleri Marina, Garbuglia Anna Rosa, Giombini Emanuela, Taibi Chiara, Lionetti Raffaella, D'Offizi Gianpiero, Capobianchi Maria R
Abstract excerpt
BACKGROUND: The impact of pre-existing variants in hepatitis C virus (HCV) quasispecies, carrying resistance-associated mutations (RAMs), on the outcome of treatment with direct acting antiviral agents (DAA) is debated and it is complicated by the lack of knowledge of quasispecies distribution between the viral reservoir (liver) and the circulating compartment. OBJECTIVE: To evaluate NS3 protease heterogeneity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
